Tetra Bio-Pharma (OTC: TBPMF) Initiates Additional Studies on Leading Drug Candidate ARDS-003
Tetra Bio-Pharma and Targeted Pharmaceuticals enter into an agreement to further its collaboration and co-development activities to advance Antiviral Central Nervous System Program The addressable global market for central nervous system drugs is expected to […]
